Eisai And Biogen Announce Detailed Results Of Phase II Clinical Study Of BAN2401 In Early Alzheimer's Disease At Alzheimer's Association International Conference (AAIC) 2018

Author's Avatar
Jul 26, 2018
Article's Main Image

PR Newswire